List view / Grid view

Articles

 

Issue 4, 2018

29 August 2018 | By

A US perspective on how pharma companies are preparing for Brexit, overcoming disinfectant residues with culture media neutralisers, unlocking the potential of new technology in biopharma, and much more in this issue of European Pharmaceutical Review.